Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: Results of a preliminary study
Authors:
- Peter DomePDPeter Dome
- Judit DobosJDJudit Dobos
- Xenia GondaXGXenia Gonda
- Anna SzekelyASAnna Szekely
- Maria Sasvari-SzekelyMSMaria Sasvari-Szekely
- Gabor FaludiGFGabor Faludi
- Judit LazaryJLJudit Lazary
- 1 January 2013
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 144 (3) , 269-273
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- VEGF regulates antidepressant effects of lamotrigineEuropean Neuropsychopharmacology, 2012
- Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: Differential effect of cigarette smokingCytokine, 2012
- Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic featuresTherapeutic Advances in Psychopharmacology, 2012
- Role of vascular endothelial growth factor in adult hippocampal neurogenesis: Implications for the pathophysiology and treatment of depressionBehavioural Brain Research, 2012
- Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): A pilot studyBrain Research Bulletin, 2011
- Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesisGenes & Development, 2011
- Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disordersJournal of Neural Transmission, 2010
- Induction of Neuronal Vascular Endothelial Growth Factor Expression by cAMP in the Dentate Gyrus of the Hippocampus Is Required for Antidepressant-Like BehaviorsJournal of Neuroscience, 2009
- The function of vascular endothelial growth factorBioFactors, 2009
- VEGF as a potential target for therapeutic intervention in depressionCurrent Opinion in Pharmacology, 2008